LGD 4033 (Ligandrol) by Dragon Pharma is a selective androgen receptor modulator (SARM) formulated at 15 mg per tablet. It has gained considerable attention in the research community for its potent anabolic activity in skeletal muscle with significantly reduced androgenic side effects. Commonly investigated in muscle-wasting conditions, LGD 4033 is also explored for performance enhancement, recovery, and bone strength support.
Mechanism of Action
LGD 4033 functions as a non-steroidal SARM that selectively binds to androgen receptors in muscle and bone tissues. Upon binding, it triggers a cascade of gene expression that enhances protein synthesis, muscle fiber retention, and nitrogen balance, while sparing other androgen-sensitive tissues like the prostate.
This selectivity is what makes LGD 4033 an attractive research alternative to testosterone. It mimics the anabolic effects of traditional androgens with fewer undesirable outcomes such as hair loss, acne, or liver toxicity. Researchers also value its predictable pharmacokinetics, oral bioavailability, and reversible suppression profile after cessation.
Key Features & Benefits
- Potent Anabolic Agent: Promotes lean muscle mass and strength increases in short- and long-term studies.
- High Androgen Receptor Affinity: Targets skeletal muscle and bone while sparing reproductive tissues.
- Oral Bioavailability: 15 mg tablets allow for convenient non-injectable research applications.
- Supports Recovery: Investigated for post-injury muscle preservation and rehabilitation models.
- Trusted Manufacturing: Dragon Pharma ensures precise dosing and consistency in every tablet.
Legal Disclaimer
Disclaimer: LGD 4033 is provided for research and development purposes only. It is not intended for human consumption or therapeutic use. Handle in accordance with applicable lab safety protocols.
Frequently Asked Questions
Research shows that LGD 4033 can cause temporary suppression of endogenous testosterone during administration, which generally recovers after discontinuation.
LGD 4033 is studied for muscle wasting, strength recovery, lean mass development, and bone health in both clinical and athletic research environments.
Reported research-based effects include testosterone suppression, mild water retention, and transient changes in lipid or liver markers.
Ligandrol selectively binds to androgen receptors in muscle tissue, triggering gene transcription that promotes anabolic growth and recovery.
